White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

Wiebenga O. T.; Schoonheim M. M.; Hulst H. E.; Nagtegaal G. J. A.; Strijbis E. M. M.; Steenwijk M. D.; Polman C. H.; Pouwels P. J. W.; Barkhof F.; Geurts J. J. G.

首页> 外文期刊>AJNR. American journal of neuroradiology >White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

【24h】

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

机译：纳他珠单抗治疗复发-复发性多发性硬化症第一年的白色物质扩散变化

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND AND PURPOSE: Natalizumab treatment strongly affects relapsing-remitting multiple sclerosis, possibly by restraining white matter damage. This study investigated changes in white matter diffusivity in patients with relapsing-remitting multiple sclerosis during their first year of natalizumab treatment by using diffusion tensor imaging.

机译：背景与目的：那他珠单抗治疗可能通过抑制白质损伤而强烈影响复发缓解型多发性硬化症。这项研究使用扩散张量成像技术研究了那他珠单抗治疗的第一年复发-缓解型多发性硬化症患者白质扩散率的变化。

著录项

来源
《AJNR. American journal of neuroradiology》 |2016年第6期|共8页
作者
Wiebenga O. T.; Schoonheim M. M.; Hulst H. E.; Nagtegaal G. J. A.; Strijbis E. M. M.; Steenwijk M. D.; Polman C. H.; Pouwels P. J. W.; Barkhof F.; Geurts J. J. G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis [J] . Wiebenga O. T., Schoonheim M. M., Hulst H. E., AJNR. American journal of neuroradiology . 2016,第6期

机译：纳他珠单抗治疗复发-复发性多发性硬化症第一年的白色物质扩散变化
2. A Diffusion Longitudinal MR Imaging Study in Normal-Appearing White Matter in Untreated Relapsing-Remitting Multiple Sclerosis [J] . F.G. Garaci, V. Colangelo, A. Ludovici, American Journal of Neuroradiology . 2007,第3期

机译：未治疗的复发-缓解型多发性硬化症中正常出现的白色物质的扩散纵向MR成像研究
3. CLINICAL OUTCOMES WERE BETTER FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS WHO REMAINED ON NATALIZUMAB COMPARED TO THOSE WHO SWITCHED TO ORAL OR INJECTABLE THERAPIES AFTER 2 YEARS IN THE TYSABRI (R) OBSERVATIONAL PROGRAM (TOP) [J] . Butzkueven Helmut, Kappos Ludwig, Spelman Tim, Journal of Neurology, Neurosurgery and Psychiatry . 2018,第6期

机译：与在Tysabri（R）观察计划（TOP）后2年后切换到口腔或可注射疗法的人相比，临床结果更好
4. Early axonal damage in normal appearing white matter in Multiple Sclerosis: novel insights from multi-shell diffusion MRI [C] . Silvia De Santis, Tobias Granberg, Russell Ouellette, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2017

机译：多发性硬化中正常出现白质的早期轴突损伤：来自多壳扩散MRI的新颖见解
5. An investigation of early relapsing-remitting multiple sclerosis patients using diffusion tensor imaging and spectroscopy. [D] . Zaini, Wan Hazlin. 2013

机译：使用扩散张量成像和光谱法对早期复发缓解型多发性硬化症患者进行调查。
6. White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis [O] . O.T. Wiebenga, M.M. Schoonheim, H.E. Hulst, 2016

机译：白质扩散在纳莱格宫治疗的第一年变化复发 - 延长多发性硬化症
7. PND19 Aggressive Natalizumab Treatment For Jc Virus-Negative Relapsing-Remitting Multiple Sclerosis? Cost-Effectiveness Of First-Line Versus Second-Line Natalizumab Treatment [O] . McQueen R.B., Nair K.V., Vollmer T.L., 2014

机译：PND19积极的那他珠单抗治疗Jc病毒阴性复发-缓解型多发性硬化症？一线与二线纳他珠单抗治疗的成本-效果

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

摘要

著录项

相似文献

相关主题

期刊订阅